ACS Chemical Biology · 2012 · 125 citations · 23 references
MedicineOncologyPharmacologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingOncogenic ProliferationOncogenic Signaling PathwaysReceptor Tyrosine Kinase SignalingTargeted Cancer TherapyTyrosine Kinase InhibitorsCell-permeable ProbesKinase Signaling InhibitorsOncogenic TransformationProtein Kinase InhibitorsSrc Family Kinase InhibitorsSrc Family KinasesTargeted Inhibitor DesignTyrosine Kinase Inhibition
Generating highly selective probes to interrogate protein kinase function in biological studies remains a challenge, and new strategies are required. Herein, we describe the development of the first highly selective and cell-permeable inhibitor of c-Src, a key signaling kinase in cancer. Our strategy involves extension of traditional inhibitor design by appending functionality proposed to interact with the phosphate-binding loop of c-Src. Using our selective inhibitor, we demonstrate that selective inhibition is significantly more efficacious than pan-kinase inhibition in slowing the growth of cancer cells. We also show that inhibition of c-Abl kinase, an off-target of most c-Src inhibitors, promotes oncogenic cell growth.
23
The selectivity of protein kinase inhibitors: a further update
Jenny Bain, Lorna Plater, Matt Elliott et al. · Biochemical Journal · 2007 · 2.5K citations · Full text
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis, Jeremy P. Hunt, Sanna Herrgård et al. · Nature Biotechnology · 2011 · 2.4K citations · Full text